PhaseBio Pharmaceuticals
- Revenue$320 KFY, 2020
- Market Capitalization$28.5 M2022-06-23
OverviewSuggest Edit
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. The Company uses its proprietary recombinant biopolymers called elastin-like polypeptides (ELPs) to improve the stability, bioavailability, activity and ease of administration of proteins and peptides, with the goal of achieving greater potency, fewer side effects and better patient compliance.
| Type | Public | |
| Founded | 2002 | |
| HQ | Malvern, PA, US | Map |
| Website | phasebio.com |
Key People/Management at PhaseBio Pharmaceuticals
Jonathan Mow
Clay Thorp
Susan Arnold
Glen Burkhardt
John Lee
Kris Hanson
PhaseBio Pharmaceuticals Office Locations
PhaseBio Pharmaceuticals Financials and Metrics
PhaseBio Pharmaceuticals Revenue
| USD | |
|---|---|
Revenue (FY, 2020) | 320.0k |
Net income (FY, 2020) | (98.6m) |
EBIT (FY, 2020) | (84.9m) |
Market capitalization (23-Jun-2022) | 28.5m |
Closing stock price (23-Jun-2022) | 0.7 |
Cash (31-Dec-2020) | 28.1m |
EV | 12.5m |
| USD | Q3, 2017 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|
Net Income | (7.7m) | (19.0m) | (7.3m) | (16.5m) | (27.9m) | (14.9m) | (43.0m) |
Depreciation and Amortization | 68.0k | 82.0k | 31.0k | 74.0k | 124.0k | 54.0k | 111.0k |
Accounts Payable | (39.0k) | 558.0k | 225.0k | 1.2m | (114.0k) | (712.0k) | 4.3m |
Cash From Operating Activities | (5.8m) | (10.2m) | (8.7m) | (18.9m) | (27.1m) | (23.8m) | (32.8m) |
PhaseBio Pharmaceuticals Cybersecurity Score
PhaseBio Pharmaceuticals Environment, Social & Governance (ESG) Ratings
PhaseBio Pharmaceuticals Online and Social Media Presence
298 Twitter followers
PhaseBio Pharmaceuticals has 298 Twitter Followers. The number of followers has increased 3.5% month over month and increased 5.3% quarter over quarter
PhaseBio Pharmaceuticals's Trends
Twitter Engagement Stats for @PhaseBio
166
Tweets
139
Following
298
Followers
3
Tweets last 30 days
1.3
Avg. likes per Tweet
66.7%
Tweets with engagement
PhaseBio Pharmaceuticals News and Updates
Thinking about buying stock in PhaseBio Pharmaceuticals, Aileron Therapeutics, JetBlue Airways, Aurora Cannabis, or Remark Holdings?
Thinking about buying stock in Altimmune Inc., Dare Bioscience Inc., Phasebio Pharmaceuticals Inc., Stoneco Ltd., or Tilray Inc.?
PhaseBio Pharmaceuticals Blogs
Nancy Hutson, PhD
Clay Thorp
Susan Arnold, PhD
William D. Humphries
REVERSE-IT
Jonathan Birchall
PhaseBio Pharmaceuticals Frequently Asked Questions
When was PhaseBio Pharmaceuticals founded?
PhaseBio Pharmaceuticals was founded in 2002.
Who are PhaseBio Pharmaceuticals key executives?
PhaseBio Pharmaceuticals's key executives are Jonathan Mow, Clay Thorp and Susan Arnold.
How many employees does PhaseBio Pharmaceuticals have?
PhaseBio Pharmaceuticals has 22 employees.
What is PhaseBio Pharmaceuticals revenue?
Latest PhaseBio Pharmaceuticals annual revenue is $320 k.
What is PhaseBio Pharmaceuticals revenue per employee?
Latest PhaseBio Pharmaceuticals revenue per employee is $14.5 k.
Who are PhaseBio Pharmaceuticals competitors?
Competitors of PhaseBio Pharmaceuticals include Cosmo Pharmaceuticals, Sangamo Therapeutics and PanOptica.
Where is PhaseBio Pharmaceuticals headquarters?
PhaseBio Pharmaceuticals headquarters is located at 1 Great Valley Pkwy #30, Malvern.
Where are PhaseBio Pharmaceuticals offices?
PhaseBio Pharmaceuticals has an office in Malvern.
How many offices does PhaseBio Pharmaceuticals have?
PhaseBio Pharmaceuticals has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies